Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: ROBERT TOWARNICKI - CELL PATHWAYS INC (CLPA).


(PAL213) ROBERT TOWARNICKI - CELL PATHWAYS INC (CLPA CLPA CC-Link Partner Association
CLPA Club Loisirs et Plein Air (Montpellier, France)
CLPA Child Labour Programme of Action (national plan to eliminate child labour in South Africa) 
). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 6/2/02. Tickers featured: CLPA. Complete text approximately 3000 words. Document # PAL213.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: ROBERT TOWARNICKI - CELL PATHWAYS INC (CLPA).(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:89
Previous Article:CEO INTERVIEW: GARY LYONS - NEUROCRINE BIOSCIENCES INC (NBIX).
Next Article:CEO INTERVIEW: GARO ARMEN - ANTIGENICS INC (AGEN).
Topics:



Related Articles
CELL PATHWAYS EXPECTS DELAY IN PREVATAC'S COMMERCIALIZATION.
CELL PATHWAYS REPORTS NET LOSS FOR SECOND QUARTER.
CELL PATHWAYS' NDA SUBMISSION ACCEPTED FOR FILING.
ROBERT TOWARNICKI - CELL PATHWAYS INC (CLPA).
CELL PATHWAYS SIGNS PALADIN FOR APTOSYN MARKETING IN CANADA.
CEO INTERVIEW: ROBERT TOWARNICKI - CELL PATHWAYS INC (CLPA).
CELL PATHWAYS REPORTS DECREASED NET LOSS FOR SECOND QTR.
CEO INTERVIEW: ROBERT TOWARNICKI - CELL PATHWAYS INC (CLPA).
Cell Pathways' CEO Robert J. Towarnicki talks to The Wall Street Transcript.
CEO INTERVIEW: ROBERT TOWARNICKI - NUCLEONICS INC.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles